93413-04-8 (7S)-7-{[(2S,9S,9aS)-9-hydroxy-2-(2-methylpropyl)-3-oxo-2,3,9,9a-tetrahydro-1H-imidazo[1,2-a]indol-9-yl]methyl}-6,7-dihydroquinazolino[3,2-a][1,4]benzodiazepine-5,13-dione |
Product Name |
(7S)-7-{[(2S,9S,9aS)-9-hydroxy-2-(2-methylpropyl)-3-oxo-2,3,9,9a-tetrahydro-1H-imidazo[1,2-a]indol-9-yl]methyl}-6,7-dihydroquinazolino[3,2-a][1,4]benzodiazepine-5,13-dione |
Synonyms |
[2S-[2a,9b,9(R*),9ab]]-6,7-Dihydro-7-[[2,3,9,9a-tetrahydro-9-hydroxy-2-(2-methylpropyl)-3-oxo-1H-imidazo[1,2-a]indol-9-yl]methyl]quinazolino[3,2-a][1,4]benzodiazepine-5,13-dione;93413-04-8 |
Molecular Formula |
C31H29N5O4 |
Molecular Weight |
535.5931 |
InChl |
InChI=1/C31H29N5O4/c1-17(2)15-22-29(39)36-25-14-8-5-11-20(25)31(40,30(36)34-22)16-23-26-32-21-12-6-3-9-18(21)28(38)35(26)24-13-7-4-10-19(24)27(37)33-23/h3-14,17,22-23,30,34,40H,15-16H2,1-2H3,(H,33,37)/t22-,23-,30-,31-/m0/s1 |
CAS Registry Number |
93413-04-8 |
Molecular Structure |
|
Density |
1.48g/cm3 |
Refractive Index |
1.761 |
MSDS |
Material Safety Data Sheet |